Background: Acute gastrointestinal bleeding (GIB) is a life-threatening abdominal emergency and can be treated by transarterial embolization (TAE). Rehemorrhage and poor outcome are associated with several clinical factors. This study investigated the clinical and angiographic parameters associated with treatment failure for patients with acute GIB undergoing TAE. Methods: Sixty-seven patients who had angiographic evidence of contrast extravasation and who received subsequent TAE were included in this study. Treatment failure was defined as continuous or recurrent bleeding that required surgery within 7 days after the bleeding episode and/or death within 1 month. Univariate and multivariate logistic regression was applied to analyze the clinical and angiographic parameters affecting treatment failure. Results: Patients were divided into two groups: success (n ¼ 35, 52.3%) and failure (n ¼ 32, 47.7%). In the failure group, 22 patients (68.9%) re-bled and then received surgery. With the aid of angiographic localization, 68.2% (15 of 22 patients) survived after surgery. The other 10 patients who did not receive surgery died within 30 days. Several clinical and angiographic parameters analyzed by multivariate analysis were associated with treatment failure ( p < 0.05), including presence of coagulopathy [odds ratio (OR), 14.7], number of supplying arteries >1 (OR, 13.2), and a distance of >5 cm (OR, 6.3) during TAE. Conclusion: Angiographic parameters associated with treatment failure in patients undergoing TAE are established when the number of supplying arteries is >1, and a distance of >5 cm. Patients with these risk factors should be watched carefully for recurrence in the postprocedural period.
Introduction
Acute nonvariceal gastrointestinal bleeding (GIB) is a lifethreatening abdominal emergency, as an admission diagnosis and as a complication during hospitalization, with reported mortality rates of approximately 4e10%. 1, 2 In the overwhelming majority of patients with acute GIB, the bleeding either resolves spontaneously or can be controlled endoscopically. Despite conservative medical treatment or endoscopic intervention, however, severe bleeding occurs in 5e10% of patients who require surgery or angiographic intervention, either to locate or to control the source of bleeding. 3, 4 The outcome of surgery in acute GIB largely depends upon the identification of the bleeding site, the general condition of the patient, and the type of operation. 5 A preoperative site-specific diagnosis is extremely important. It can help determine whether a localized, minimally invasive procedure or a large, blind resection should be performed. This, in turn, has a profound influence on morbidity and mortality. 6 In patients with an unclear bleeding source or with poor risk status for surgical intervention, visceral arteriography has been advocated to identify bleeding sources, and, at the same time, to provide control of the GIB by embolization of particulate matter into the bleeding artery. 7 Surgery is typically reserved for those patients whose bleeding fails to respond to endoscopic and angiographic treatments.
With recent advances in endovascular technology, transarterial embolization (TAE) for GIB has gained much attention. An increasing number of patients with GIB are being referred to the endovascular suite after failed endoscopic management. 8, 9 Since 1972, TAE has been performed extensively, and has been shown to be effective at controlling hemorrhage and decreasing mortality. 9e12 Nevertheless, in spite of advances in technology and methods, which have allowed more patients to be successfully treated via TAE, angiographic control of GIB still fails in a number of patients, necessitating surgical intervention.
Several clinical risk factors are associated with rehemorrhage and poor outcome, such as presence of coagulopathy, 11,13e15 presence of multiple comorbidities 13, 14 or use of coils as the only embolic agent. 14, 15 However, angiographic factors predicting treatment failure have not been addressed. The purpose of the present retrospective study was to analyze the association of demographic, clinical, and angiographic characteristics with treatment failure.
Methods

Patient identification
This study was conducted retrospectively at a tertiary referral medical center between January 2006 and March 2011. A search of the institutional database for interventional radiology identified 107 consecutive patients who underwent diagnostic angiography for GIB. Angiographic evidence of bleeding was detected in 67 patients. TAE was subsequently performed in these 67 patients, who were included in this study. There were 44 men and 23 women, with a mean age of 67.7 years (range ¼ 21e94 years). All 67 patients had been referred by gastroenterologists and were considered on clinical grounds to be actively bleeding at the time of angiography. All patients had failed to respond to conservative medical therapy consisting of volume replacement, antacids, or H2 receptor blocking agents (in patients with upper gastrointestinal bleeding), and all patients experienced continued bleeding despite attempted endoscopic treatment.
The study was approved by the institutional review board for human investigation (TSGHIRB-099-05-221). Written informed consent was waived because of strict maintenance of patient anonymity and the observational nature of the study. This study complies with the standards of Declaration of Helsinki and current ethical guidelines.
Methods and techniques for transarterial embolization
Informed consent for the procedure was obtained from the conscious patient or the immediate family. The right common femoral artery was accessed, and selective arteriography of the celiac trunk and superior mesenteric artery was performed with a 4.1-F catheter (RC-1, Cook, Bloomington, IN, USA) and a non-ionic contrast medium (Ultravist, Schering AG, Berlin, Germany) was injected at a flow rate of 3e3.5 mL/ second. Inferior mesenteric arteriography required a lower injection rate of 2e2.5 mL/second. Images were obtained with the digital subtraction technique. When GIB was confirmed and localized unequivocally by a demonstration of contrast extravasation at angiography, superselective embolization was performed, with a 2.7-F hydrophilic angiographic catheter (Radiofocus Guide Wire M, Terumo, Tokyo, Japan) coaxially inserted into a 4.1-F catheter.
The principle for TAE is similar with other studies. 9, 15, 16 For embolotherapy, we delivered vascular platinum microcoilsof various diameters and lengths close to the site of contrast medium extravasation and in areas proximal and distal to the bleeding site via superselective catheterization. If the guide wire could not be extended into the distal portion of the bleeding site, the portion distal to the bleeding point was embolized by using gelatin sponge pieces (Spongostan, Johnson & Johnson Medical, Midrand, South Africa), followed by embolization of the proximal portion with microcoils. If direct entry into the bleeding artery was not possible, it was treated by means of flow-directed injection of gelatin sponge pieces. When a combination of agents was used, gelatin sponge was injected into the desired territory until stagnation was observed, and coils were then placed inside the target vessel to complete the occlusion. Finally, a postembolization arteriography was performed to confirm the absence of contrast extravasation. The choice of embolic agent and the final number and selection of embolized arteries in the procedure was case dependent and was ultimately left to the discretion of the radiologists who had 21 years (C.Y.Y.), 10 years (C.H.L.), and 7 years (W.C.C.) of experience in interventional radiology, respectively. The patients then received supportive medical therapy in the intensive care unit. They were observed in particular for ischemic complications. Patients with subsequent bleeding were referred for surgery or endoscopy, but not for repeat arteriography.
Clinical data
All clinical, laboratory, and medication information, as well as the treatment given and outcome data, were obtained from the medical records. Acute GIB was defined as hematemesis, melena, or bloody stool within 24 hours prior to embolization. Blood loss was quantified by measuring the hemoglobin concentration and the amount of blood products transfused 0e2 days prior to embolization. The numbers of transfused units of packed cells, fresh frozen plasma and platelets before and after embolization were recorded. Patients who met one of the following criteria were identified as having coagulopathy: international normalized ratio (INR) > 1.6, partial thromboplastin time > 45 seconds, or thrombocytopenia with a platelet count < 50,000 per cubic millimeter (5 Â 10 10 per L). Clinical success was defined as clinical cessation of bleeding (clearing of nasogastric aspirates and/or melena with no evidence of bleeding on follow-up endoscopy) and stabilization of the hemoglobin level after the procedure. If a patient had continuous or recurrent active bleeding which required surgery within 7 days after the angiographic procedure, and/or death occurred within 1 month after the primary procedure, the procedure was termed a failure. Repeat embolizations were excluded from the analysis, regardless of the outcome.
From the medical records, the following variables were recorded: demographic data, clinical diagnoses, major comorbidities, medications, hemoglobin concentration before and after embolization, total transfusion requirements, presence of shock, coagulation profiles, post-procedure complications, and mortality rates.
Angiographic image review
The names and identifying patient record numbers were electronically removed from all images for each angiographic examination prior to loading of the cases onto a workstation for review. The age and sex of the patient and the date of the angiography were not removed. Two gastrointestinal radiologists (W.C.C. and C.Y.Y., with 7 and 21 years of experience in abdominal imaging and interventional radiology, respectively), who were blinded to patient identification and surgical/ angiographic diagnosis, independently reviewed each angiographic study and recorded the angiographic findings.
The angiographic findings were individually recorded as follows: (1) anatomic location of contrast extravasation; (2) bleeding vascular territory; (3) number of arteries supplying the bleeding point; (4) the shortest intra-arterial distance between the catheter tip at time of embolization and the bleeder and (5) presence of pseudoaneurysm. Discrepancies between the two reviewers were resolved by further consensus readings, and these consensus readings were also used for analysis.
Short-term follow-up
The final etiology of GIB was traced by consensus analysis (W.C.C. and C.Y.Y.) incorporating the history and all imaging findings and histological and autopsy findings, if available. The follow-up medical records were reviewed to determine whether the patients experienced ongoing blood loss and whether subsequent surgery or repeat angiographic procedures were required. After completion of angiographic intervention, a rebleeding episode was defined as a subsequent bleeding episode that occurred after the initial bleed had stopped within 72 hours. The 30 day mortality rates were recorded. We also checked whether the patient had further blood transfusions to replace ongoing blood loss, whether the patient required further intervention in the form of a repeat embolization or surgery to stop bleeding and whether the patient died because of acute hemorrhage or hemorrhage-related complications.
Statistical methods
Statistical analyses were performed using SPSS version 14.0 software (SPSS Inc., Chicago, IL, USA). Descriptive statistics were reported as mean and standard deviation (SD) or median and range for continuous variables. Categorical variables were expressed as frequencies and percentages. Oneway analysis of variance (ANOVA) was used to compare the two groups (treatment failure and success) of patients. A p value of <0.05 was considered significant. Significant variables for treatment failure on one-way ANOVA (i.e., variables with p values <0.05) were selected for multivariate analysis using multiple logistic regression. A p value <0.05 was deemed to indicate a significant difference.
Results
Sixty-seven consecutive patients (44 male, 23 female; mean age ¼ 67.7 years; range ¼ 21e94 years) undergoing diagnostic angiography followed by TAE were included in this study. There were 28 total procedures performed for foregut pathology, 29 for mid-gut lesions, nine for hindgut hemorrhage and one transpapillar GIB. Demographic data and bleeding parameters at the time of presentation of GIB for patients in the success and failure groups are summarized in Table 1 . There were no significant differences in sex, age, comorbidities, drug history, coagulation profile, platelet count, blood transfusion during the episode, and presence of shock between the two groups. There was a higher proportion of patients with uremia in the failure group than in the success group (n ¼ 9 vs. 3; p < 0.05). Patients in the failure group had lower hemoglobin levels (6.4 vs. 7.4 mg/dL; p < 0.05) during onset of acute bleeding and a higher proportion of coagulopathy (n ¼ 9 vs. 3; p < 0.05).
Causes of bleeding and angiographic findings
The causes of GIB, its duration prior to angiography, angiographic findings and embolization variables of the two groups are listed in Table 2 . Causes of hemorrhage included bleeding ulcer [n ¼ 50 (74.6%)], intra-abdominal malignancy [n ¼ 5 (7.5%)], infection [n ¼ 2 (3.0%)], trauma [n ¼ 2 (3.0%)], and angiodysplasia [n ¼ 8 (11.9%)]. There were no significant differences between the two groups in the causes and anatomic localization of bleeding, bleeding vascular territory, and duration of bleeding prior to angiography. In two patients, the cause of bleeding remained obscure. Endoscopic findings suggested hemobilia when endoscopic exploration of the case of transpapillar bleeding was performed. The etiology of bleeding was hemorrhagic cholecystitis confirmed by surgical pathology. There were no significant differences in embolic agents used, whether gelatin sponges, coils, or both.
The number of patients with more than one supplying artery ( Fig. 1) and a distance (defined as the shortest intraarterial distance between the catheter tip at the time of embolization and the bleeder) of >5 cm (Fig. 2) were both significantly different between the two groups. There was no significant difference between the two groups in the presence of pseudoaneurysm.
Analysis of treatment failure
The clinical and angiographic findings predicting treatment failure are listed in The presence of coagulopathy is the most important factor associated with treatment failure. Uremia, which was often present in patients who had coagulation disorders, was not identified as a predictor of treatment failure in the multivariate analysis because of interaction between these two factors. b Distance is defined as the shortest intra-arterial distance between the catheter tip to the bleeder at the time of embolization.
Post-procedural complications
Four complications were attributed to the embolization procedure. One patient, who had abdominal pain after embolization of the gastroduodenal artery with coils and gelatin sponges, was diagnosed with duodenal ischemia after endoscopy. Endoscopic findings consisted of multiple duodenal erosive lesions, which were interpreted as ischemic changes. The patient had no predisposing factors for ischemia, such as earlier abdominal surgery or radiation therapy. The symptoms resolved with conservative therapy. A second patient, with self-resolving abdominal pain after embolization of the gastroduodenal artery with coils and gelatin sponges, was also suspected of having transient duodenal ischemia based on his symptoms. The patient developed moderate epigastric pain and nausea hours after embolization, and the endoscopist reported only non-specific erythema of the duodenal mucosa. The symptoms improved the next day and resolved after 2 days without treatment. Visceral organ infarction complicated recovery in one patient. Partial infarction of the right liver lobe ensued after embolization for traumatic arteriobiliary fistula in a patient with cirrhosis of the liver associated with portal vein thrombosis. Conservative treatment was successful. Lastly, a patient with an underlying coagulopathy developed an inguinal hematoma at the puncture site after embolization, which was treated conservatively.
Two patients developed transient renal failure during the peri-procedural period, which could not be directly attributable to the embolization procedure. There were no cases of permanent renal insufficiency.
Short-term outcome and in-hospital survival
Thirty-five (52%) of 67 patients who underwent TAE had no clinical evidence of re-bleeding and hence received no further treatment for GIB after 7 days. Treatment failure occurred in 32 (48%) patients, with continuous or recurrent active bleeding within 7 days which required surgery, and/or who died within 1 month. Surgical interventions were performed in 22 (68%) of 32 patients, with clinical evidence of persisting or recurrent GIB, which was confirmed by the transfusion of more units of packed cells and lower hemoglobin concentrations after TAE. Seven of the 22 patients died during their subsequent hospitalization (persistent GIB, n ¼ 6; sepsis, n ¼ 1). The other 10 (32%) patients, who did not receive surgery, died from causes related to persistent bleeding (n ¼ 5), cardiac failure (n ¼ 2), acute respiratory distress syndrome (n ¼ 2), or septic shock (n ¼ 1). The overall inhospital mortality was 25.4% (17 of 67 patients).
Discussion
TAE is widely accepted for the termination of acute GIB resistant to medical and endoscopic hemostasis, especially in those considered a poor risk for surgery. 7, 11 This practice is supported by the results of our study with a treatment success rate of 52.2% (35 of 67 patients). To our knowledge, prior authors have documented higher success rates than ours associated with mesenteric embolization for acute GIB. 9, 15 However, by their definition of procedural success rate, these studies did include patients with early rebleeding and with inhospital mortality related to this bleeding episode as their procedural success group. The two conditions are defined as treatment failure in our study, which can reflect a patient's clinical outcome more accurately. In our study, we also analyzedthe clinical and angiographic risk factors influencing treatment failure, which have yet to be addressed adequately.
Despite recent developments in a variety of endoscopic therapies, failure of endoscopic management occurs quite frequently. About 5e10% of patients still require surgery or angiographic intervention, either to locate or to control the source of bleeding. Endoscopic identification of the source artery may be limited by the considerable amount of blood and/or feces present in the GI tract. However, the result of surgical intervention largely depends upon the identification of the bleeding point. 5 Diagnostic angiography is necessary if a bleeding site cannot be identified endoscopically or if a transarterial intervention is being considered as a treatment option.
In examining the angiographic findings of patients who received TAE, we were able to identify certain risk factors which predicted treatment failure. We found statistical evidence that multiple arteries supplying the bleeding site (OR ¼ 13.19; 95% CI ¼ 2.7e64.1; p ¼ 0.001) and a distance between the catheter tip and the bleeding point of >5 cm (OR ¼ 6.33; 95% CI ¼ 1.6e24.7; p ¼ 0.008) are high-risk factors for treatment failure. It was suggested that inflammatory or ischemic reactions after embolization could trigger vasodilation of the intramural collaterals, resulting in rebleeding. 9 Re-canalization through the extensive collaterals in the duodenal blood supply in upper GIB, or collaterals between the vasa recta in lower GIB, could be responsible for recurrence after technical success (cessation of bleeding at the time of embolization). With more supplying vessels, the bleeding site could potentially have more collaterals related to it. When a dual or multiple blood supply exists, retrograde filling might occur through an alternate route. Moreover, embolization at a too-proximal location (because of vessel tortuosity or vasospasm) may allow refilling of distal collateral circulation. Lang reported that recurrent duodenal ulcer bleeding could be effectively eliminated with a superselective approach to occlude the bleeding intramural artery. 17 In a series of patients with lower gastrointestinal hemorrhage, Peck et al 18 proposed a similar mechanism for rehemorrhage after embolization with absorbable gelatin sponges and microcoils.
Apparently, clinical factors play an important role in the failure of TAE in acute GIB. TAE, like surgery, does not treat the underlying disease, such as peptic ulcer disease or coagulopathy. Encarnacion et al 11 found an association between coagulopathy and clinical failure after TAE in GIB (OR ¼ 2.9). Furthermore, Defreyne et al 9 reported that rebleeding and coagulopathy after embolization were directly correlated with in-hospital mortality. In our series, this association was confirmed with the finding of an even stronger significance (OR ¼ 14.74). This highlights the importance of correcting any coagulation disorder in patients with GI hemorrhage before, during, and after intervention.
Although in this study hemoglobin concentration was not identified as a predictor of re-bleeding in the multivariate analysis because of its interaction with coagulopathy ( p ¼ 0.065), recurrence of bleeding was associated with a lower hemoglobin level (mean ¼ 6.4 mg/dL vs. 7.4 mg/dL; p < 0.05) in the univariate analysis. This may point to the severe and abrupt nature of the GIB in the failure group. Signs of active bleeding and shock at admission are proposed risk factors for rehemorrhage after endoscopic hemostasis, and could be an additional risk factor for early recurrence after embolization. 9, 19 However, we found no correlation between the presence of shock and rebleeding.
Arterial embolization in the upper GI tract is generally considered very safe because of the rich collateral supply to the stomach and duodenum. The risk of significant ischemia after embolization is known to increase in patients with previous surgery within the same area, or with embolic agents that can advance far into the vascular bed such as tissue adhesives or gelatin sponge powder. 17, 20 Lang 17 reported duodenal stenosis as a sequela of ischemia in seven of 28 patients with embolization of terminal vessels, mostly when tissue adhesive was used, and in only two of 29 patients with more proximal occlusion of the gastroduodenal artery. In lower GIB, several authors have confirmed that polyvinyl alcohol particles (PVAs) and platinum microcoils are safe and curative. PVAs injected just proximally to the vas rectum, seem to flow along the path of least resistance, particularly the ruptured vas rectum, and to reduce the risk of bowel ischemia. Nicholson et al 16 reported that proximal occlusion was considered responsible for ischemic colonic strictures in three (21%) of 14 patients, all of whom were treated conservatively.
The absence of major bowel ischemic events in our series indicated that we delivered the embolic material in the right amount and at the right place; we used platinum microcoils and gelatin sponge plugs rather than PVAs or glue. Embolic material was delivered only when a superselective approach into the bleeding vessel could be achieved, while carefully avoiding filling normal branches. Thus, we narrowed the risk area by performing superselective embolization into the ruptured mural artery.
Our study has several limitations. Firstly, patients without angiographic evidence of GIB (intraluminal contrast leakage) were not included, because the exact localization for TAE could not be determined. In addition, we also did not include patients with acute GIB who directly underwent surgical intervention. The optimal time to perform angiography or surgery is sometimes a difficult clinical decision, because of the intermittent nature of GIB. Secondly, this study was retrospective. Although criteria were applied for TAE, the use of coils and the number of gelatin sponge pieces used were not standardized. The experience of the three radiologists differed. In spite of these, the study does represent a large single-center experience with a variety of GI pathologies from various locations. Further clarification of the role of angiographic risk factors in predicting longterm survival requires prospective, randomized, control studies.
In conclusion, in patients with endoscopically unmanageable acute GIB, TAE is advised as the first approach to treatment, because it offers effective and safe nonsurgical healing in a large number of cases. In addition, patients with certain risk factors, such as a distance of >5 cm, more than one supplying artery or the presence of coagulopathy, are at higher risk for treatment failure and should be watched carefully for recurrence in the post-procedural period. Even with possible treatment failure, diagnostic angiography can still provide additional informationto facilitate a better therapeuticplan.
